Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen: May 10, 2007

Premium
Qiagen recently introduced the FlexiTube siRNA, a line of siRNAs against customer-specified targets available in one nanomolar amounts.
 
According to the company, FlexiTube allows customers to order a small number of siRNAs in cost-effective quantities. The siRNAs come lyophilized in tubes.
 
Qiagen also introduced this week the MiScript line of microRNA assay technologies.
The line incorporates a technology that allows researchers to identify multiple miRNAs from a single cDNA reaction in a given biological sample, the company said.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.